Accolade (Nasdaq: ACCD), a US-based healthcare company, announced on Thursday that it has named Elizabeth Nabel, MD and Jeff Brodsky as its new directors.

Dr Nabel is the executive vice president for strategy at ModeX Therapeutics. She served for eleven years as the president of Brigham and Women's Hospital. She directed the National Heart, Lung, and Blood Institute of the National Institutes of Health and also serves on the boards of directors of Moderna, a pharmaceutical company, and Medtronic, a medical device company.

Brodsky is the vice chairman at Morgan Stanley and member of its operating committee. He has over 30 years of experience at Morgan Stanley and held various leadership roles across the human resources function. He also serves on the Safe Horizon board of directors and is an executive in residence at the University of Michigan's Ross School of Business, where he earlier served on the advisory board.